P N Leigh

Prevalence of depression in a 12‐month consecutive sample of patients with ALS

P. Leigh, P. Wicks, S. Abrahams, 2007, European journal of neurology.

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial

A Al-Chalabi, D J Burn, D. Burn, 2013, The Lancet Neurology.

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

A Al-Chalabi, D J Brooks, D. Brooks, 2005, Brain : a journal of neurology.

Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS

A Al-Chalabi, D J Brooks, D. Brooks, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET

R B Banati, A Al-Chalabi, D J Brooks, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.

A Al-Chalabi, D J Brooks, P. Grasby, 2005, Brain : a journal of neurology.

The management of motor neurone disease

A Al-Chalabi, J Moxham, Janel O. Johnson, 2003, Journal of neurology, neurosurgery, and psychiatry.

Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis.

A Al-Chalabi, J. Powell, A. Al-Chalabi, 1999, Human molecular genetics.

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

P. Leigh, V. Meininger, L. Lacomblez, 1996, Lancet.